Divi's Laboratories (DIVISLAB) — Financial Results

Divi's Laboratories reported a 69.9% YoY increase in net profit to ₹87.22 crores for the quarter ended March 31, 2025, driven by strong operational performance, while revenue growth was not specified in the filing.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this financial results affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 31 March 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 31 March 2025

BAJFINANCE Bajaj Finance Limited Financial Results JINDALSTEL JINDAL STEEL LIMITED Financial Results AMBUJACEM Ambuja Cements Limited Corporate Action TECHM Tech Mahindra Limited Financial Results BAJAJFINSV Bajaj Finserv Limited Financial Results OBEROIRLTY Oberoi Realty Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.